Patrick J Polsunas, MD
Physical Medicine and Rehabilitation · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · James Petros MD Inc · 21 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Polsunas’s office at (408) 528-8833 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
Original Medicare doctor bills
$99,022
Medicare paid this office $99,022 for 128 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 100 | $32,139 | $123 |
| Principal care management services for a single high-risk disease, first 30 minutes provided personally by qualified health care professional, per calendar month. | 53 | $14,092 | $77 |
| Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan tha | 89 | $13,313 | $77 |
| Long return visit (40+ min) | 38 | $10,796 | $171 |
| Administration of psychological or neuropsychological test, first 30 minutes | 67 | $3,774 | $41 |
See all 12 services
| Return visit (30+ min) | 100 | $32,139 | $123 |
| Principal care management services for a single high-risk disease, first 30 minutes provided personally by qualified health care professional, per calendar month. | 53 | $14,092 | $77 |
| Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan tha | 89 | $13,313 | $77 |
| Long return visit (40+ min) | 38 | $10,796 | $171 |
| Administration of psychological or neuropsychological test, first 30 minutes | 67 | $3,774 | $41 |
| New patient visit (60+ min) | 15 | $2,940 | $196 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 84 | $2,898 | $15 |
| Ultrasonic guidance for needle placement | 27 | $2,155 | $58 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 18 | $1,869 | $104 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 12 | $1,544 | $129 |
| Short return visit (20+ min) | 13 | $1,235 | $88 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 41 | $136 | None |
Who their Medicare patients are
128 Original Medicare patients in 2024. Average age 74 · Under 65 12% · 85 and older 19% · Women 64% · Also on Medicaid 16% · Health risk score 1.32. At or below the middle of the specialty; the typical physical medicine and rehabilitation clinician is at 1.53.
Conditions among them: High blood pressure 74% · Diabetes 37% · Coronary heart disease 31% · Depression 19% · Chronic kidney disease 17% · Heart failure 16% · Atrial fibrillation 16% · Cancer 13% · COPD 12% · Stroke 12%.
The office billed $994,742, Medicare allowed $124,687 and paid $99,022; for 1,369 services of 48 kinds; $139 of it was for drugs given in the office and $98,883 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Drugs they prescribed that Part D paid
$67,096
Pharmacies billed $67,096 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 36% of their Part D prescriptions (331 of 913) in 2024. Above the middle of the specialty; the typical physical medicine and rehabilitation clinician is at 12%. Long-acting opioids: 7% of their opioid prescriptions.
889 generic and 24 brand-name prescriptions · $67,096 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Levorphanol | 11 | $20,228 | $1,839 |
| Buprenorphine-Naloxone | 51 | $11,611 | $228 |
| Lidocaine | 31 | $7,943 | $256 |
| Buprenorphine | 18 | $4,935 | $274 |
| Hydrocodone-Acetaminophen | 188 | $3,915 | $21 |
See all 22 drugs
| Levorphanol | 11 | $20,228 | $1,839 |
| Buprenorphine-Naloxone | 51 | $11,611 | $228 |
| Lidocaine | 31 | $7,943 | $256 |
| Buprenorphine | 18 | $4,935 | $274 |
| Hydrocodone-Acetaminophen | 188 | $3,915 | $21 |
| Oxycodone-Acetaminophen | 30 | $2,665 | $89 |
| Buprenorphine | 32 | $2,010 | $63 |
| Gabapentin | 141 | $1,948 | $14 |
| Duloxetine | 54 | $1,143 | $21 |
| Tramadol | 35 | $944 | $27 |
| Cyclobenzaprine | 28 | $762 | $27 |
| Lubiprostone | 11 | $681 | $62 |
| Baclofen | 35 | $658 | $19 |
| Celecoxib | 21 | $550 | $26 |
| Pregabalin | 37 | $531 | $14 |
| Oxycodone | 33 | $426 | $13 |
| Tizanidine | 16 | $270 | $17 |
| Hydromorphone | 13 | $161 | $12 |
| Methocarbamol | 15 | $152 | $10 |
| Meloxicam | 13 | $126 | $10 |
| Lorazepam | 11 | $23 | $2 |
| Promethazine | 12 | $21 | $2 |
Year by year
| 2024 | 913 | 119 | 36% (331) | 3% | $67,096 |
| 2023 | 742 | 105 | 37% (277) | 4% | $74,269 |
| 2022 | 272 | 83 | 50% (136) | None | $24,694 |
| 2020 | 94 | 19 | 0% (0) | None | $5,119 |
| 2019 | 147 | 43 | 0% (0) | 13% | $8,456 |
| 2018 | 102 | 23 | 0% (0) | None | $2,844 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 18 drugs
| Buprenorphine-Naloxone | 35 | $5,247 | $150 |
| Hydrocodone-Acetaminophen | 152 | $4,110 | $27 |
| Buprenorphine | 30 | $4,069 | $136 |
| Lubiprostone | 11 | $2,840 | $258 |
| Gabapentin | 131 | $2,238 | $17 |
| Duloxetine | 20 | $1,574 | $79 |
| Oxycodone-Acetaminophen | 29 | $1,246 | $43 |
| Cyclobenzaprine | 47 | $1,055 | $22 |
| Tramadol | 30 | $1,052 | $35 |
| Baclofen | 33 | $741 | $22 |
| Oxycodone | 43 | $637 | $15 |
| Tizanidine | 15 | $360 | $24 |
| Cephalexin | 12 | $309 | $26 |
| Pregabalin | 15 | $296 | $20 |
| Methocarbamol | 17 | $192 | $11 |
| Nortriptyline | 11 | $122 | $11 |
| Meloxicam | 11 | $108 | $10 |
| Lorazepam | 15 | $33 | $2 |
2022: 6 drugs
| Hydrocodone-Acetaminophen | 78 | $2,239 | $29 |
| Gabapentin | 36 | $726 | $20 |
| Oxycodone-Acetaminophen | 18 | $584 | $32 |
| Oxycodone | 15 | $481 | $32 |
| Cyclobenzaprine | 12 | $392 | $33 |
| Baclofen | 14 | $314 | $22 |
2019: 1 drug
| Gabapentin | 13 | $218 | $17 |
2018: 1 drug
| Gabapentin | 11 | $131 | $12 |
Money from drug and device companies
$256 in 2025
| 2025 | 7 | 8 | None | $256 |
| 2024 | 3 | 3 | None | $90 |
| 2023 | 5 | 22 | None | $443 |
| 2022 | 4 | 6 | None | $1,088 |
| 2021 | 1 | 6 | None | $412 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Mml US | Reactiv8 | $58 | 1 payment
|
| Abbott Laboratories | Eterna | $46 | 2 payments
|
| Si-Bone | None | $42 | 1 payment
|
| Nalu Medical | Nalu Neurostimulation System | $29 | 1 payment
|
| Curonix | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A | $27 | 1 payment
|
| Boston Scientific | Intracept | $27 | 1 payment
|
See all 8 published payments
| Mml US | Meals · 2025-09-25 | Reactiv8 | $58 |
| Nalu Medical | Meals · 2025-09-16 | Nalu Neurostimulation System | $29 |
| Curonix | Meals · 2025-07-10 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A | $27 |
| Abbott Laboratories | Meals · 2025-04-24 | Eterna | $26 |
| SPR Therapeutics | Meals · 2025-04-10 | Sprint Pns System | $26 |
| Abbott Laboratories | Meals · 2025-04-07 | Proclaim | $21 |
| Si-Bone | Meals · 2025-03-25 | None | $42 |
| Boston Scientific | Meals · 2025-01-22 | Intracept | $27 |
See earlier years (2024, 2023, 2022, 2021)
2024: $90
| Vertex Pharmaceuticals | None | $53 | 1 payment
|
| Boston Scientific | None | $21 | 1 payment
|
| Si-Bone | None | $16 | 1 payment
|
2023: $443
| Nalu Medical | Nalu Neurostimulation System | $187 | 10 payments
|
| Boston Scientific | Wavewriter Alpha Prime 16 | $176 | 8 payments
|
| Pfizer | Comirnaty | $39 | 2 payments
|
| Curonix | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A | $24 | 1 payment
|
| Collegium Pharmaceutical | Belbuca | $18 | 1 payment
|
2022: $1,088
| Stimwave Technologies | Stimq Receiver Stimulator Kit Channel A US W/Receiver | $670 | 1 payment
|
| Boston Scientific | Wavewriter Alpha Prime 16 | $245 | 2 payments
|
| Abbott Laboratories | Ionicrf | $153 | 2 payments
|
| Hikma Pharmaceuticals USA | Kloxxado | $21 | 1 payment
|
2021: $412
| Medtronic | Intellis | $412 | 6 payments
|
Professional record
- NPI
- 1366972549
- Licence
- PA MT213968
- Trained
- University of Pittsburgh School of Medicine, 2017
- Group
- James Petros MD Inc
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 208100000X (208100000X); Student in a training program (390200000X)
- Mailing address
- 3600 Forbes Avenue, Forbes Tower Plaza Suite 140, Pittsburgh, PA, 15213
- NPI first listed
- 2017-06-19
- NPI last updated
- 2025-04-21
- NPI record certified
- 2025-04-21
This is when the NPI record was last certified, not a medical board exam.